FDAFDA · Food and drugs·Recall number D-0129-2018
Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15
Published December 27, 2017 · Recall initiated: August 10, 2017
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Premier Pharmacy Labs Inc
- Distributor
- Michigan, Maryland, Minnesota, North Carolina, Ohio, Florida
- Lot
- Lot # NEO071317MMDSA BUD: 01/19/2018 Lot # NEO071317MMDSC BUD: 01/19/2018 Lot # NEO071317MMDSF BUD: 01/19/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.